The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.
Haynes, Andrew
Haynes, Andrew
Abstract
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2020-03
Type
Article
Collections
Citation
Bishton MJ, Rule S, Wilson W, et al. The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival [published online ahead of print, 2020 Mar 9]. Br J Haematol. 2020;10.1111/bjh.16555. doi:10.1111/bjh.16555.
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141